CS logo
small CS logo
ICIMED Instituto de Investigación en Ciencias Médicas

San Jose, Costa Rica
Research institute in San José
Edificio Kabat, Av. 9, Gral Cañas, San José

About ICIMED Instituto de Investigación en Ciencias Médicas


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
14
Total Rows: 1

Clinical Trials at ICIMED Instituto de Investigación en Ciencias Médicas


During the past decade, ICIMED Instituto de Investigación en Ciencias Médicas conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111133221111440000000000221100Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
2017-06-30
2023-12-31
Active, not recruiting
1,101
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms
2018-11-20
2019-04-03
Completed
173
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
2019-01-23
2023-08-01
Recruiting
30
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-12-27
2024-12-31
Active, not recruiting
438
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
2019-10-10
2023-07-07
Recruiting
3,160

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 14Hoffmann-La Roche: 14

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at ICIMED Instituto de Investigación en Ciencias Médicas


According to Clinical.Site data, the most researched conditions in "ICIMED Instituto de Investigación en Ciencias Médicas" are "Influenza" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Alzheimer's Disease" (1 trials), "Breast Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "ICIMED Instituto de Investigación en Ciencias Médicas" in a lesser frequency.

Clinical Trials Intervention Types at ICIMED Instituto de Investigación en Ciencias Médicas


Most popular intervention types in "ICIMED Instituto de Investigación en Ciencias Médicas" are "Drug" (13 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (4 trials), "Baloxavir Marboxil" (3 trials), "Ipatasertib" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ICIMED Instituto de Investigación en Ciencias Médicas


The vast majority of trials in "ICIMED Instituto de Investigación en Ciencias Médicas" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at ICIMED Instituto de Investigación en Ciencias Médicas


Currently, there are NaN active trials in "ICIMED Instituto de Investigación en Ciencias Médicas". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ICIMED Instituto de Investigación en Ciencias Médicas, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ICIMED Instituto de Investigación en Ciencias Médicas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusRecruiting: 7Recruiting: 7Active, not recruiting: 3Active, not recruiting: 3Completed: 3Completed: 3Terminated: 1Terminated: 1